1. Home
  2. ASIC vs ALVO Comparison

ASIC vs ALVO Comparison

Compare ASIC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

N/A

Current Price

$26.39

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Logo Alvotech

ALVO

Alvotech

N/A

Current Price

$5.58

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASIC
ALVO
Founded
2018
2013
Country
United States
Luxembourg
Employees
203
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ASIC
ALVO
Price
$26.39
$5.58
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
★ $29.10
$6.80
AVG Volume (30 Days)
51.7K
★ 953.0K
Earning Date
10-21-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.18
N/A
Revenue
★ $424,339,000.00
N/A
Revenue This Year
$27.91
$11.96
Revenue Next Year
$25.28
$17.65
P/E Ratio
$22.21
★ $18.20
Revenue Growth
★ 23.41
N/A
52 Week Low
$16.35
$2.94
52 Week High
$29.00
$9.05

Technical Indicators

Market Signals
Indicator
ASIC
ALVO
Relative Strength Index (RSI) 44.42 61.19
Support Level $18.75 $3.10
Resistance Level $27.22 N/A
Average True Range (ATR) 0.80 0.29
MACD -0.30 -0.03
Stochastic Oscillator 11.16 66.93

Price Performance

Historical Comparison
ASIC
ALVO

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: